Connect with us

Health & Beauty

Dr Ahmed El Kaffas: Smile Ambassador and a Pioneer in Dentistry

Published

on

Dr Ahmed El Kaffas

Beauty comes from within and a cheerful soul calls for a beautiful smile, one that has a story behind it and because your smile matters the most, we were granted with Dr Ahmed El Kaffas aka the smile ambassador!

Dr Ahmed El Kaffas, a true pioneer in the field of dentistry and a person who has contributed so much to the field by playing a vital role in placing Egypt on the map as a top destination for seeking dental help.

He is the founder and manager of Capital Dental Clinic. a clinic that has witnessed many smile transformations and changed the lives of many by boosting their self confidence.

Dr El Kaffas is also the very first to introduce the technology of 3N veneers in Egypt! Which originally is a German technology and because of him, it is now available exclusively in Capital Dental Clinics and with that, he has opened up doors of possibilities for Egypt by attracting foreigners for medical tourism purposes.

Being behind so many smiles and helping patients feel confident about their looks, Dr El Kaffas is a true inspiration for many aspiring dentists and a doctor to look up to. Not only for his innovation and introduction to new technologies, but also for his being so keen on delivering patients with premium dental treatment.

Click to comment

Leave a Reply

Your email address will not be published. Required fields are marked *

Health & Beauty

Egypt Signs Deal To Receive A Supply of COVID-19 Vaccine From Oxford University

Published

on

By

Remember when we told you that there are a number of trials being done for several vaccines? Remember how we told you Egypt had already signed a deal to get one of these vaccines and was trying to sign yet another deal to get the Oxford University’s vaccine?

Well, great news once again! The Egyptian Drug Authority had announced the signing of a deal with AstraZeneca to get a supply of the Oxford University’s vaccine for coronavirus without disclosing the number of doses or the delivery date.

Ahmed Salman is an Egyptian researched who is among the team working on the vaccine at Oxford university and he said in in a phone-in with Amr Adib that the vaccine is currently in the human trials phase.

Salman further explained that the vaccine consists of a version of coronavirus that infects chimpanzees. This helps disables the virus ability to reproduce, as to prepare the body to destroy COVID-19 once infected.

Health and Protective Affairs Consultant to the President Mohamed Awad Tag el-Din stated in a phone-in that Egypt was expected to receive a share of the COVID-19 vaccine developed by Oxford University. This phone call was held earlier this month.

The consultant pointed out that the company producing the vaccine developed by Oxford University has granted India the right to produce two billion doses. He also added that clinical trials of other vaccines are ongoing in China, India, and other countries.

Now, we just hope and pray that these clinical trials go well and that soon enough, we can get our hands on an actual vaccine.

 

Continue Reading

Health & Beauty

What You Need to Know About Ongoing Trials For A Coronavirus Vaccine

Published

on

By

We understand that you’re starving for some good news and because the word ‘vaccine’ is the most appealing this year, we have gathered most of the information and updates you need to know regarding finding a vaccine for COVID-19.

So yes, all what follows are good news aimed at lifting up your spirits.

1st Clinical Test in Japan of Coronavirus Vaccine to Start June 30

1st clinical test in Japan of coronavirus vaccine to start June 30

A clinical test of a potential vaccine for the new coronavirus developed by medical startup Anges Inc. will start on June 30 in Japan, Osaka Gov. Hirofumi Yoshimura made the announced yesterday, hoping that it can be put it into practice next year.

“I think it will be the first clinical test (of a coronavirus vaccine) on humans in Japan,” Yoshimura told a press conference.

So when can we expect it? Yoshimura said it is possible to produce the DNA vaccine for 200,000 people by the end of this year and they are applying for state approval between spring and fall of next year, if of course the human trial proves its effectiveness in preventing COVID-19 infection.

China’s COVID-19 Vaccine Candidate Shows Promise in Human Trials

China National Biotec Group (CNBG) announced on Tuesday that its experimental coronavirus vaccine has succeeded in triggering antibodies in clinical trials and that the company is planning the late-stage human trials in foreign countries.

The vaccine has been developed by a Wuhan-based research institute affiliated to CNBG’s parent company China National Pharmaceutical Group (Sinopharm).

It was found to have induced high-level antibodies in all inoculated people without serious adverse reaction, according to the preliminary data from a clinical trial initiated in April which included 1,120 healthy participants aged between 18 and 59.

UAE Stem Cell Treatment Makes ‘Positive’ Progress In Helping To Cure COVID-19

The UAE is joining in the battle against the virus! It’s not a vaccine but a treatment which is just as good.

Arabian Business reported that stem cell treatment for patients suffering from the virus has shown “positive” results, according to Dr. Fatima Al Kaabi, consultant and head of Hematology and Oncology Department at Sheikh Khalifa Medical City, and senior specialist in research related with the stem cell project.

The treatment was given to 73 individuals with mild and moderate symptoms.

67 percent of patients of those who received stem cell therapy for the virus have been cured, with improvements in condition occurring after four days after the treatment was administered.

“All the patients who were treated with stem cells, recovered in less than seven days, three times faster than those treated with conventional methods,” Dr Al Kaabi said, according to Arabian Business.

Egypt Signs Deal to Receive Japan’s Avigan and Attempting To Get Oxford University Vaccine

FILE PHOTO: Small bottles labeled with a "Vaccine COVID-19" sticker and a medical syringe are seen in this illustration taken taken April 10, 2020. REUTERS/Dado Ruvic/Illustration/File Photo

Where does Egypt stand in all of this? Egypt signed a deal to receive Japan’s Avigan and is attempting to get the vaccine developed at Oxford University.

Avigan helps in accelerating the recovery of patients and Egypt is exerting efforts to get a share of the vaccine developed by Oxford University.

 

Continue Reading

Health & Beauty

Ahalyna: First Electronic Hospital For Online Coronavirus Consultation

Published

on

By

With the number of coronavirus patients on the rise, people with mild symptoms choose to be quarantined at home. Some are forced to with the unavailability of public hospitals.

Not all private hospitals accept coronavirus patients and so with the need to get the treatments at home, this hospital has chosen to go digital and serve patients with exactly what they need!

Ahalyna hospital is an electronic one, founded by Egyptian doctors, who aim at helping those who are self-isolated at home and not getting their treatments at hospitals.

All the hospitals’ online services are completely for free and so far, around 200 doctors have taken part in this wonderful and quite helpful initiative.

 

The hospitals have doctors from different specialties, who are all keen in helping those patients who can’t afford to get treatments at a public or private hospitals.

But keep in mind that this isn’t a substitute to hospitals but merely a solution for those who can’t find a spot at hospitals, and whom physical health allows them to be quarantined at home.

They are also calling out for volunteers. Visit their Facebook page now for more information.

Continue Reading
Event calender
Cinema calender

Cinema calender

Facebook

Fashion

Categories

Top Posts

Trending

X